- Home
- FSFG vs DERM Comparison
FSFG vs DERM Comparison
Compare FSFG & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- DERM
- Stock Information
- Founded
- FSFG 2008
- DERM 2014
- Country
- FSFG United States
- DERM United States
- Employees
- FSFG N/A
- DERM N/A
- Industry
- FSFG Savings Institutions
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- FSFG Finance
- DERM Health Care
- Exchange
- FSFG Nasdaq
- DERM Nasdaq
- Market Cap
- FSFG 177.8M
- DERM 165.6M
- IPO Year
- FSFG 2008
- DERM 2021
- Fundamental
- Price
- FSFG $27.02
- DERM $7.05
- Analyst Decision
- FSFG Strong Buy
- DERM Strong Buy
- Analyst Count
- FSFG 3
- DERM 3
- Target Price
- FSFG $31.50
- DERM $12.67
- AVG Volume (30 Days)
- FSFG 8.2K
- DERM 131.2K
- Earning Date
- FSFG 10-23-2025
- DERM 11-11-2025
- Dividend Yield
- FSFG 2.37%
- DERM N/A
- EPS Growth
- FSFG 130.94
- DERM N/A
- EPS
- FSFG 3.10
- DERM N/A
- Revenue
- FSFG $79,674,000.00
- DERM $56,397,000.00
- Revenue This Year
- FSFG N/A
- DERM $28.10
- Revenue Next Year
- FSFG $7.37
- DERM $53.84
- P/E Ratio
- FSFG $8.70
- DERM N/A
- Revenue Growth
- FSFG 10.53
- DERM N/A
- 52 Week Low
- FSFG $21.63
- DERM $3.54
- 52 Week High
- FSFG $30.94
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- FSFG 51.08
- DERM 45.87
- Support Level
- FSFG $26.67
- DERM $7.00
- Resistance Level
- FSFG $27.67
- DERM $7.12
- Average True Range (ATR)
- FSFG 0.57
- DERM 0.27
- MACD
- FSFG -0.08
- DERM -0.01
- Stochastic Oscillator
- FSFG 48.20
- DERM 26.75
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.